URGENT: The COVID-19 epidemic is severely impacting the progress of ALS research at the ALS Therapy Development Institute. If you are able to give, will you please provide an immediate gift to fund our lab?


TDI 197

This small molecule is being tested by scientists at the ALS Therapy Development Institute for its potential to help support the unfolded protein response in ALS patients. 


Type: Small Molecule
Stage: Active
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

Currently, we are conducting in vitro validation experiments on this small molecule. The next step will be determining whether or not this potential treatment can be moved into in vivo research studies being conducted at the Institute.

Comment on this Topic

(All comments are moderated before they appear here.)